Sebocytes are the key regulators of androgen homeostasis in human skin

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 793-800

  Fritsch, Martin ^b   Orfanos, Constantin E ^a   Zouboulis, Christos C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

17 hydroxysteroid dehydrogenase; 3 hydroxysteroid dehydrogenase; 3 hydroxysteroid dehydrogenase; 5 reductase; Androgen metabolism; Androgen receptor; Keratinocytes; Melanocytes; Sebaceous glands; 5 4 isomerase

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; 4,7BETA DIMETHYL 4 AZACHOLESTAN 3 ONE; ANDROGEN; ANDROGEN RECEPTOR; DNA FRAGMENT; FINASTERIDE; PRASTERONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CELL CULTURE; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SUBSTRATE; ENZYME SUBUNIT; GENE EXPRESSION REGULATION; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MELANOMA CELL; PRIORITY JOURNAL; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEBACEOUS GLAND; SKIN CELL;

EID: 0035016799     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01312.x     Document Type: Article

References (60)

1. Andersson S, Moghrabi N: Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143-147, 1997
2. Ando Y, Yamaguchi Y, Hamada K, Yoshikawa K, Itami S: Expression of mRNA for androgen receptor, 5α-reductase and 17β-hydroxystetoid dehydrogenase in human dermal papilla cells. Br J Dermatol 141:840-845, 1999
3. Azzolina B, Ellsworth K, Andersson S, Geissler W, Bull HG, Harris GS: Inhibition of rat α-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Molec Biol 61:55-64, 1997
4. Baillie AH, Thomson J, Milne JA: The distribution of hydroxysteroid dehydrogenase in human sebaceous glands. Br J Dermatol 78:451-457, 1966
5. Bayne EK, Flanagan J, Einstein M, et al: Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp. Br J Dermatol 141:481-491, 1999
6. Berkovitz GD, Brown TR, Fujimoto M: Aromatase activity in human skin fibroblasts grown in cell culture. Steroids 50:281-295, 1987
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
8. Chen W-C, Zouboulis ChC, Orfanos CE: The 5α-reductase system and its inhibitors; recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 193:177-184, 1996
9. Chen W-C, Zouboulis ChC, Fritsch M, Blume-Peytavi U, Kordelja V, Goerdt S, Orfanos CE: Evidence of heterogeneity and quantitative differences of the type 1 5α-reductase expression in cultured human skin cells - first evidence of its presence in melanocytes. J Invest Dermatol 110:84-89, 1998
10. Courchay G, Boyera N, Bernard BA, Mahe Y: Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol 9:169-176, 1996
11. Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F: Metabolic effects of 12-month percutaneous dehydroepiandrosterone teplacement therapy in postmenopausal women. J Endocrinol 150:S43-S50, 1996
12. Dufort I, Soucy P, Labrie F, Luu-The V: Molecular cloning of human type 3 3α-hydroxysteroid dehydrogenase that differs from 20α-hydroxysteroid dehydrogenase by seven amino acids. Biochim Biophys Res Commun 228:474-479, 1996
13. Dumont M, Luu-The V, Dupont E, Pelletier G, Labrie F: Characterization expression, and immunohistochemical localisation of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in human skin. J Invest Dermatol 99:415-421, 1992
14. Eicheler W, Dreher M, Hoffmann R, Happle R, Aumüller G: Immunhistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 133:371-376, 1995
15. Ellsworth K, Azzolina B, Baginsky W, et al: MK386: a potent, selective inhibitor of the human type 1 5α-reductase. J Steroid Biochem Molec Biol 58:377-384, 1996
16. Flamigni C, Collins WP, Koullapis EN, Craft I, Dewhurst CJ, Sommerville IF: Androgen metabolism in human skin. J Clin Endocrinol 32:737-743, 1971
17. Geissler WM, Davis DL, Wu L, et al: Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genet 7:34-39, 1994
18. Grino PB, Griffin JE, Wilson JD: Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 126:1165-1172, 1990
19. Harris G, Azzolina B, Baginsky W, et al: Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc Natl Acad Sci USA 89:10787-10791, 1992
20. Hay JB, Hodgins MB: Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol 79:29-39, 1978
21. Horton R: Dihydrotestosterone is a peripheral paracrine hormone. J Androl 13:23-27, 1992
22. Hughes SV, Robinson E, Bland R, Lewis HM, Stewart PM, Hewison M: 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology 138:3711-3718, 1997
23. Imperato-McGinley J, Gautier T, Cai L-Q, Yee B, Epstein J, Pochi P: The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 76:524-528, 1993
24. Khanna M, Qin K-N, Wang RW, Cheng K-C: Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J Biol Chem 270:20162-20168, 1995
25. Kuttenn F, Couillin P, Girard F, et al: Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224-231, 1985
26. Labrie F: Intracrinology. Mol Cell Endocrinol 78:C113-C118, 1991
27. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G: Structure function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Molec Biol 43:805-826, 1992
28. Labrie F, Luu-The V, Lin S-X, Labrie C, Simard J, Breton R, Bélanger A: The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 62:148-158, 1997
29. Liao S, Kokontis J, Sai T, Hiipakka RA: Androgen receptors: structures, mutations, antibodies and cellular dynamics. J Steroid Biochem 34:41-51, 1989
30. Lookingbill DP, Horton R, Demers LM, Egan N, Marks JG Jr, Santen RJ: Tissue production of androgens in women with acne. J Am Acad Dermatol 12:481-487, 1985
31. Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez Solache I, Singh M, Labrie F: Characterization expression, and immunohistochemical localization of 5α-reductase in human skin. J Invest Dermatol 102:221-226, 1994
32. Martel C, Rhéaume E, Takahashi M, Trudel J, Luu-The V, Simard J, Labrie F: Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Molec Biol 41:597-603, 1992
33. Messenger AG: The control of hair growth: an overview. J Invest Dermatol 101:4S-9S, 1993
34. Milewich L, Kaimal V, Shaw CB, Sontheimer RD: Epidermal keratinocytes: a source of 5α-dihydrotestosterone production in human skin. J Clin Endocrinol Metab 62:739-746, 1986
35. Milne JA: The metabolism of androgens by sebaceous glands. Br J Dermatol 81 (Suppl. 2):23-28, 1969
36. Mowszowicz I, Wright F, Vincens M, et al: Androgen metabolism in hirsute patients treated with cyproterone acetate. J Steroid Biochem 20:757-761, 1984
37. Orfanos CE: Antiandrogenos en dermatologia. Arch Argent Dermat 32:51-55, 1982
38. Patel S, Einstein M, Geissler W, Wu L, Andersson S: Immunohistochemical analysis of steroid 5α-reductase type 1 in human scalp and prostate. Ann N Y Acad Sci 784:27-39, 1996
39. Peltoketo H, Nokelainen P, Piao Y-S, Vihko R, Vihko P: Two 17β-hydroxysteroid dehydrogenises (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7. J Steroid Biochem Molec Biol 69:431-439, 1999
40. 4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 52:32-36, 1969
41. Puerto AM, Mallol J: Regional differences of the androgenic metabolic pattern in subjects affected by male pattern baldness. Rev Bsp Fisiol 46:289-296, 1990
42. Russell DW, Wilson JD: Steroid 5α-reductases: two genes/two enzymes. Annu Rev Biochem 63:25-61, 1994
43. Sansone G, Reisner RM: Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin - a possible pathogenic factor in acne. J Invest Dermatol 56:366-372, 1971
44. Sawaya ME, Penneys NS: Immunohistochemical distribution of aromatase and 3β-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol 19:309-314, 1992
45. Schürer N, Kohne A, Schliep V, Barlag K, Goerz G: Lipid composition and synthesis of HaCaT cells, an immortalized human keratinocyte line, in comparison with normal human adult keratinocytes. Exp Dermatol 2:179-185, 1993
46. Sonoda T, Itami S, Kurata S, Takayasu S: Testosterone metabolism by cultured human beard outer root sheath cells in comparison with epidermal keratinocytes. J Derm Sci 6:214-218, 1993
47. Sperling LC, Heimer WL: Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. J Am Acad Dermatol 28:669-683, 1993
48. Tadokoro T, Itami S, Hosokawa K, Terashi H, Takayasu S: Human genital melanocytes as androgen target cells. J Invest Dermatol 109:513-517, 1997
49. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S: Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 105:209-214, 1995
50. Thiboutot DM, Knaggs H, Gilliland K, Hagari S: Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 136:166-171, 1997
51. Thiboutot D, Martin P, Volikas L, Gilliland K: Oxidative activity of the type 2 isozyme of 17β-hydroxysteroid dehydrogenase predominates in intact and homogenized human sebaceous glands. J Invest Dermatol 111:390-395, 1998
52. Thiboutot D, Gilliland K, Light J, Lookingbill D: Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 135:1041-1045, 1999
53. Thigpen AE, Cala KM, Russell DW: Characterization of chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes. J Biol Chem 268:17404-17412, 1993
54. Tóth I, Szécsi M, Julesz J, Faredin I: Activity and inhibition of 3-beta-ydroxysteroid dehydrogenase/delta-5-4-isomerase in human skin. Skin Pharmacol 10:160-168, 1997
55. Wraight CJ, Liepe IJ, White PJ, Hibbs AR, Werther GA: Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J Invest Dermatol 111:239-242, 1998
56. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S: Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969, 1993
57. Xia L, Zouboulis Ch, Detmar M, Mayer-da-Silva A, Stadler R, Orfanos CE: Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in-vitro model. J Invest Dermatol 93:315-321, 1989
58. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WE: Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1.2, and 3. Endocrinology 81:3594-3598, 1996
59. Zouboulis ChC, Xia L, Akamatsu H, et al: The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 196:21-31, 1998
60. Zouboulis ChC, Seltmann H, Neitzel H, Orfanos C: Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011-1020, 1999